ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.39
+0.57 (7.29%)
At close: Mar 13, 2026, 4:00 PM EDT
8.40
+0.01 (0.12%)
After-hours: Mar 13, 2026, 7:59 PM EDT

ImmunityBio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
88.33143.43265.45104.64181.1
Short-Term Investments
154.486.381.012.54136.02
Cash & Short-Term Investments
242.82149.81266.46107.18317.12
Cash Growth
62.09%-43.78%148.60%-66.20%230.12%
Accounts Receivable
42.572.36---
Other Receivables
0.050.292.021.891.33
Total Trade Receivables
42.622.652.021.891.33
Inventory
0.918.27---
Other Current Assets
28.5323.8525.631.515.9
Total Current Assets
314.88184.59294.08140.58334.35
Net Property, Plant & Equipment
147.27170.46182.63189.45119.17
Other Intangible Assets
---201.42
Goodwill
13.9515.9317.09--
Long-Term Investments
7.387.137.777.477.2
Other Long-Term Assets
18.424.832.884.866.78
Total Assets
501.9382.93504.45362.36468.91
Accounts Payable
6.986.739.221.0211.42
Accrued Expenses
46.8440.5842.7141.8351.39
Short-Term Debt
---431.9299.24
Current Portion of Leases
7.547.475.242.653.01
Other Current Liabilities
0.40.171.143.473.94
Total Current Liabilities
61.7554.9458.28500.86369
Long-Term Debt
801.71746.28836.95241.27306.35
Long-Term Leases
33.4534.8239.9447.9537.07
Other Long-Term Liabilities
104.5635.01155.2122.090.41
Total Long-Term Liabilities
939.72816.121,032311.32343.83
Total Liabilities
1,001871.061,090812.18712.82
Common Stock
0.10.090.070.040.04
Additional Paid-in Capital
3,1972,8852,3751,9311,720
Accumulated Other Comprehensive Income
28.961.20.010.180
Retained Earnings
-3,727-3,375-2,962-2,378-1,962
Total Common Shareholders' Equity
-500.47-489.1-586.99-447.33-242.17
Minority Interest
0.90.971.05-2.49-1.74
Shareholders' Equity
-499.57-488.13-585.94-449.82-243.91
Total Liabilities & Equity
501.9382.93504.45362.36468.91
Total Debt
842.69788.57882.14723.77645.66
Net Cash (Debt)
-599.87-638.76-615.68-616.59-328.55
Net Cash Per Share
-0.65-0.91-1.21-1.54-0.84
Book Value
-500.47-489.1-586.99-447.33-242.17
Book Value Per Share
-0.54-0.70-1.15-1.12-0.62
Tangible Book Value
-514.42-505.03-604.08-467.33-243.59
Tangible Book Value Per Share
-0.56-0.72-1.19-1.17-0.63
Updated Feb 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q